These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 3039589

  • 1. The pyrolysis of cannabinoids.
    Tjeerdema RS.
    Rev Environ Contam Toxicol; 1987; 99():61-81. PubMed ID: 3039589
    [No Abstract] [Full Text] [Related]

  • 2. Cannabinoid concentrations in Canada's regulated medical cannabis industry.
    Mammen G, de Freitas L, Rehm J, Rueda S.
    Addiction; 2017 Apr; 112(4):730-732. PubMed ID: 28124470
    [No Abstract] [Full Text] [Related]

  • 3. The legal status of cannabis (marijuana) and cannabidiol (CBD) under U.S. law.
    Mead A.
    Epilepsy Behav; 2017 May; 70(Pt B):288-291. PubMed ID: 28169144
    [Abstract] [Full Text] [Related]

  • 4. [Progress in cannabis research from a pharmaceutical chemist's point of view].
    Müller CE.
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2019 Jul; 62(7):818-824. PubMed ID: 31161229
    [Abstract] [Full Text] [Related]

  • 5. Pyrolysis of cannabidiol. Structure elucidation of a major pyrolytic conversion product.
    Spronck HJ, Lousberg RJ.
    Experientia; 1977 Jun 15; 33(6):705-6. PubMed ID: 891718
    [Abstract] [Full Text] [Related]

  • 6. Toward drugs derived from cannabis.
    Mechoulam R, Carlini EA.
    Naturwissenschaften; 1978 Apr 15; 65(4):174-9. PubMed ID: 351429
    [Abstract] [Full Text] [Related]

  • 7. Sedative activity of cannabis in relation to its delta'-trans-tetrahydrocannabinol and cannabidiol content.
    Pickens JT.
    Br J Pharmacol; 1981 Apr 15; 72(4):649-56. PubMed ID: 6269680
    [Abstract] [Full Text] [Related]

  • 8. Influence of anticonvulsant cannabinoids on posttetanic potentiation at isolated bullfrog ganglia.
    Turkanis SA, Karler R.
    Life Sci; 1975 Aug 15; 17(4):569-78. PubMed ID: 1081172
    [No Abstract] [Full Text] [Related]

  • 9. Determination of Acid and Neutral Cannabinoids in Extracts of Different Strains of Cannabis sativa Using GC-FID.
    Ibrahim EA, Gul W, Gul SW, Stamper BJ, Hadad GM, Abdel Salam RA, Ibrahim AK, Ahmed SA, Chandra S, Lata H, Radwan MM, ElSohly MA.
    Planta Med; 2018 Mar 15; 84(4):250-259. PubMed ID: 29237190
    [Abstract] [Full Text] [Related]

  • 10. Cannabidiol, a non-psychoactive component of cannabis and its synthetic dimethylheptyl homolog suppress nausea in an experimental model with rats.
    Parker LA, Mechoulam R, Schlievert C.
    Neuroreport; 2002 Apr 16; 13(5):567-70. PubMed ID: 11973447
    [Abstract] [Full Text] [Related]

  • 11. Cannabis and cannabinoids.
    Med Lett Drugs Ther; 2016 Aug 01; 58(1500):97-8. PubMed ID: 27466748
    [No Abstract] [Full Text] [Related]

  • 12. Neuropsychiatric and General Interactions of Natural and Synthetic Cannabinoids with Drugs of Abuse and Medicines.
    Arellano AL, Papaseit E, Romaguera A, Torrens M, Farré M.
    CNS Neurol Disord Drug Targets; 2017 Aug 01; 16(5):554-566. PubMed ID: 28412920
    [Abstract] [Full Text] [Related]

  • 13. Historical perspective on the medical use of cannabis for epilepsy: Ancient times to the 1980s.
    Friedman D, Sirven JI.
    Epilepsy Behav; 2017 May 01; 70(Pt B):298-301. PubMed ID: 28089286
    [Abstract] [Full Text] [Related]

  • 14. Cannabis with high cannabidiol content is associated with fewer psychotic experiences.
    Schubart CD, Sommer IE, van Gastel WA, Goetgebuer RL, Kahn RS, Boks MP.
    Schizophr Res; 2011 Aug 01; 130(1-3):216-21. PubMed ID: 21592732
    [Abstract] [Full Text] [Related]

  • 15. Acute and subacute inhalation toxicity of Turkish marihuana, cannabichromene, and cannabidiol in rats.
    Rosenkrantz H, Hayden DW.
    Toxicol Appl Pharmacol; 1979 May 01; 48(3):375-86. PubMed ID: 473186
    [No Abstract] [Full Text] [Related]

  • 16. Diazotized dapsone as a reagent for the detection of cannabinoids on thin-layer chromatographic plates.
    Mali BD, Parulekar PP.
    J Chromatogr; 1988 Dec 21; 457():383-6. PubMed ID: 2854140
    [No Abstract] [Full Text] [Related]

  • 17. Commercial cannabis consumer products part 1: GC-MS qualitative analysis of cannabis cannabinoids.
    Ciolino LA, Ranieri TL, Taylor AM.
    Forensic Sci Int; 2018 Aug 21; 289():429-437. PubMed ID: 29954632
    [Abstract] [Full Text] [Related]

  • 18. Innovative development and validation of an HPLC/DAD method for the qualitative and quantitative determination of major cannabinoids in cannabis plant material.
    De Backer B, Debrus B, Lebrun P, Theunis L, Dubois N, Decock L, Verstraete A, Hubert P, Charlier C.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Dec 15; 877(32):4115-24. PubMed ID: 19932642
    [Abstract] [Full Text] [Related]

  • 19. Cannabinoids in bipolar affective disorder: a review and discussion of their therapeutic potential.
    Ashton CH, Moore PB, Gallagher P, Young AH.
    J Psychopharmacol; 2005 May 15; 19(3):293-300. PubMed ID: 15888515
    [Abstract] [Full Text] [Related]

  • 20. Commercial cannabis consumer products part 2: HPLC-DAD quantitative analysis of cannabis cannabinoids.
    Ciolino LA, Ranieri TL, Taylor AM.
    Forensic Sci Int; 2018 Aug 15; 289():438-447. PubMed ID: 30025568
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.